OBJECTIVES: This study described factors related to colorectal cancer stage at diagnosis. METHODS: Logistic regression analyses were used on data from the New York State Tumor Registry and US Census area-level social class indicators. RESULTS: After the effects of other predictors were controlled for, the odds of late-stage cancer increased as age decreased; women and African Americans were significantly more likely to have late stage than men and Whites; and individuals living in areas of low socioeconomic status (SES) were significantly more likely to be diagnosed at late stage than those living in higher SES areas. Stratified analyses showed that living in a low SES area was the most important determinant of stage for all age, race, gender and source-of-care groups. CONCLUSIONS: While all populations would benefit from the systematic use of screening socioeconomically disadvantaged groups may also benefit from targeted screening.
OBJECTIVES: This study described factors related to colorectal cancer stage at diagnosis. METHODS: Logistic regression analyses were used on data from the New York State Tumor Registry and US Census area-level social class indicators. RESULTS: After the effects of other predictors were controlled for, the odds of late-stage cancer increased as age decreased; women and African Americans were significantly more likely to have late stage than men and Whites; and individuals living in areas of low socioeconomic status (SES) were significantly more likely to be diagnosed at late stage than those living in higher SES areas. Stratified analyses showed that living in a low SES area was the most important determinant of stage for all age, race, gender and source-of-care groups. CONCLUSIONS: While all populations would benefit from the systematic use of screening socioeconomically disadvantaged groups may also benefit from targeted screening.
Authors: C P Hunter; C K Redmond; V W Chen; D F Austin; R S Greenberg; P Correa; H B Muss; M R Forman; M N Wesley; R S Blacklow Journal: J Natl Cancer Inst Date: 1993-07-21 Impact factor: 13.506
Authors: S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish Journal: N Engl J Med Date: 1993-12-30 Impact factor: 91.245
Authors: Dominik Alexander; Nirag Jhala; Chakrapani Chatla; Jon Steinhauer; Ellen Funkhouser; Christopher S Coffey; William E Grizzle; Upender Manne Journal: Cancer Date: 2005-05-15 Impact factor: 6.860
Authors: Vignesh Raman; Mohamed A Adam; Megan C Turner; Harvey G Moore; Christopher R Mantyh; John Migaly Journal: J Gastrointest Surg Date: 2019-05-31 Impact factor: 3.452
Authors: Richard G Roetzheim; Lisa K Christman; Paul B Jacobsen; Alan B Cantor; Jennifer Schroeder; Rania Abdulla; Seft Hunter; Thomas N Chirikos; Jeffrey P Krischer Journal: Ann Fam Med Date: 2004 Jul-Aug Impact factor: 5.166
Authors: Jamillah Berry; Lee Caplan; Sharon Davis; Patrick Minor; Margaret Counts-Spriggs; Roni Glover; Vickie Ogunlade; Kevin Bumpers; John Kauh; Otis W Brawley; Christopher Flowers Journal: Cancer Date: 2010-02-01 Impact factor: 6.860
Authors: Limin X Clegg; Marsha E Reichman; Barry A Miller; Benjamin F Hankey; Gopal K Singh; Yi Dan Lin; Marc T Goodman; Charles F Lynch; Stephen M Schwartz; Vivien W Chen; Leslie Bernstein; Scarlett L Gomez; John J Graff; Charles C Lin; Norman J Johnson; Brenda K Edwards Journal: Cancer Causes Control Date: 2008-11-12 Impact factor: 2.506